Category: News

Peli1 modulates the subcellular localization and activity of Mdmx

Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E...

Charting the Future of Cancer Health Disparities Research—Letter

The Balance Players of the Adaptive Immune System

Equilibrium between immune activation and suppression may be necessary to maintain immune homeostasis, because proinflammatory effector T cells (defined as antiregulatory T cells) counteract the functions of regulatory immune cells. These self-reactive...

Pleiotropic Roles for ZEB1 in Cancer

ZEB1 is a prime element of a network of transcription factors that controls epithelial-to-mesenchymal transition (EMT), a reversible embryonic transdifferentiation program that allows partial or complete transition from an epithelial to a mesenchymal s...

Defining Car-T

CAR-T Cell Therapy is a groundbreaking new cancer treatment that recently received FDA approval. But what is it exactly? Here, we explain.